A case-control study on insulin resistance, metabolic co-variates and prediction score in non-alcoholic fatty liver disease

Indian Journal of Medical Research

Volumn 129, Issue 3, 2009, Pages 285-292

  Bajaj, S ^a,b   Nigam, P ^a,c   Luthra, A ^a,d   Pandey, R M ^a,d   Kondal, D ^a,d   Bhatt, S P ^a,d   Wasir, J S ^a,c   Misra, Anoop ^a,b,c  

^a MLN MEDICAL COLLEGE   (India)

^b Diabetes Foundation   (India)

^c FORTIS HOSPITAL   (India)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Insulin resistance; Metabolic syndrome; Non alcoholic fatty liver disease; North Asian Indians

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL; AMINOTRANSFERASE; LIPID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; ECHOGRAPHY; FATTY LIVER; INDIA; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; PREVALENCE; STATISTICAL MODEL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; INDIA; INSULIN; INSULIN RESISTANCE; LIPIDS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY; TRANSAMINASES; WAIST CIRCUMFERENCE;

EID: 67649641652     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Meigs JB. Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000; 152: 908-11.
2. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
3. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-5.
4. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90: 1578-82.
5. DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract 2004; 58 (Suppl 143): 9-21.
6. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-8.
7. Garg A, Misra A. Hepatic steatosis, insulin resistance and adipose tissue disorders. J Clin Endocrinol Metab 2002; 87: 3019-22.
8. Chitturi S, Farrell GC, George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J Gastroenterol Hepatol 2004; 19: 368-74.
9. Amarapurkar A, Ghansar T. Fatty liver: experience from western India. Ann Hepatol 2007; 6: 37-40
10. Singh SP, Navak S, Swain M, Rout N, Mallik RN, Agrawal O, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gasteroenterol 2004; 25: 76-9.
11. Ford ES, Gile WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
12. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351-75.
13. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 2002; 83: 1483-96.
14. Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K, Dhingra V, et al. Association between subclinical inflammation & fasting insulin in urban young adult north Indian males. Indian J Med Res 2006; 124: 677-82.
15. Duseja A, Das A, Das R, Dhiman RK,Chawla Y, Bhansali A, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci 2007; 52: 2368-74.
16. Friedewald WT, Levy RI, Fredrikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
18. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
19. World Health Organization Western Pacific Region/International Assoc for the Study of Obesity/Int Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia: Melbourne, 2000. Available from: http://www.wpro.who.int/ NR/rdonlyres/0A35147B-B1D5-45A6-9FF2-F7D86608A4DE/0/ Redefiningobesity.pdf.
20. Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP. Waist circumference cut-off points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond) 2006; 30: 106-11.
21. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus; Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1): S5-20.
22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
23. Ramachandran A, Snehalatha C, Yamuna A, Murugesan N, Narayan KM. Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in southern India. Diabetes Care 2007; 30: 1828-33.
24. Bellentani S, Saccoccio G, Masutti F, Croce S, Brandi G,Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-7.
25. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-8.
26. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25: 883-9.
27. Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res 2007; 125: 345-54.
28. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125: 217-30.
29. Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 2003; 61: 69-76.
30. Prabhakaran D, Chaturvedi V, Ramakrishnan L, Jeemon P, Shah P, Snehi U, et al. Risk factors related to the development of diabetes in men working in a north Indian industry. Natl Med J India 2007; 20: 4-10.
31. Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 2002; 87: 5575-80.
32. Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007; 5: 496-501.
33. Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006; 55: 1604-9.
34. Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 2006; 103: 18273-7.
35. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, Asia Pacific Working Party at NAFLD. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?.J gasteroenterol Hepatol 2007; 22: 794-800.
36. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003; 19: 457-66.
37. Misra A, Vikram NK, Arya S, Pandey RM, Dhingra V, Chatterjee A, et al. High prevalence of insulin resistance in postpubertal Asian Indian children is associated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J Obes Relat Metab Disord 2004; 28: 1217-26.